Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Four big drug firms agree to $260m opioid payout hours before trial set to begin | Opioids crisis | The Guardian
EU Fines Teva $72 Million For Illegally Delaying Cheaper Generic Drug
States allege generic drug manufacturers conspired to artificially inflate prices in lawsuit
Local generic drug company is 1 of 6 accused by 20 states in price-fixing lawsuit - Philadelphia Business Journal
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.
Teva May Move Court Against Dr Reddy's For Patent Infringement | Mint
W.Va. AG Sues Opioid Makers Johnson & Johnson, Teva Pharmaceuticals - WOAY-TV
Teva Pharmaceuticals - Wikipedia
J&J's Janssen settles with WVa for $99M in opioid lawsuit | The Hill
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits | IndustryWeek
Pharma Company Found Guilty For Role In Opioid Crisis
Teva boss hits out at opioid lawsuits | Financial Times
Teva reaches settlement with Texas over opioid lawsuit | Israel National News - Arutz Sheva
Teva Found Liable For Fueling Opioid Addiction In New York | Mint
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva Faces New Opioid-Related Lawsuit in West Virginia | Ctech
Teva Class Action Claims Company Suppressed Competition For Generic Version Of MS Drug Copaxone - Top Class Actions
